Benzinga | Feb 8, 2021 04:13PM EST

Enanta Pharmaceuticals Q1 EPS $(0.41) Beats $(0.74) Estimate, Sales $31.74M Beat $28.79M Estimate

Enanta Pharmaceuticals (NASDAQ:ENTA) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.74) by 44.59 percent. This is a 163.08 percent decrease over earnings of $0.65 per share from the same period last year. The company reported quarterly sales of $31.74 million which beat the analyst consensus estimate of $28.79 million by 10.26 percent. This is a 39.62 percent decrease over sales of $52.57 million the same period last year.